Approval Year
| Substance Class |
Concept
|
| Record UNII |
FV24A4KAF3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2900376-84-1
Created by
admin on Wed Apr 02 20:24:15 GMT 2025 , Edited by admin on Wed Apr 02 20:24:15 GMT 2025
|
PRIMARY | |||
|
FV24A4KAF3
Created by
admin on Wed Apr 02 20:24:15 GMT 2025 , Edited by admin on Wed Apr 02 20:24:15 GMT 2025
|
PRIMARY | |||
|
167455052
Created by
admin on Wed Apr 02 20:24:15 GMT 2025 , Edited by admin on Wed Apr 02 20:24:15 GMT 2025
|
PRIMARY |
This is a non-substance concept
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
The mode of action of YH42946 is to inhibit the phosphorylation of HER2 tyrosine kinase domain harboring HER2-exon20 insertion and subsequently inhibit the downstream signaling such as AKT and MEK, which results in the inhibitory effects of cell proliferation
|
This is a non-substance concept